Julio Peguero is an Oncology physician affiliated with Retina Consultants of Texas. OpenAlex indexes 198 publications with 997 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7121 S. Padre Island Dr
Suite 102-101,119
Corpus Christi, TX 784124938
Telephone
361-696-6000Provider last certified this registry record 18 Mar 2026.
Industry payments
75 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Telix PharmaceuticalsProgram year20256 payments
- PFIZER INC.Program year202517 payments
- ABBVIE INC.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
36.8%Aromatase Inhibitor17.7%Exemestane74%Letrozole18%Anastrozole8%Part D<11 patientsKinase inhibitor5.2%Tagrisso38%Verzenio38%Brukinsa24%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
22.7%Serotonin-3 Receptor Antagonist7.5%Granisetron Hcl56%Ondansetron Odt44%Part D≥46 patientsCorticosteroid5.5%Prednisone100%Part D≥25 patients+ 5 more classes in this area
Blood & clotting
9%Factor Xa inhibitor4.9%Eliquis79%Fondaparinux Sodium21%Part D<11 patientsThrombopoietin Receptor Agonist2.2%Promacta100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Charles Wykoff, MD
Retina Consultants of Texas
Chirag Jhaveri, MD
Retina Consultants of Texas
Amy Schefler, MD
Retina Consultants of Texas
Saradha Chexal, MD
Retina Consultants of Texas
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”